Filing Details

Accession Number:
0001209191-18-049398
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-04 20:03:33
Reporting Period:
2018-08-30
Accepted Time:
2018-09-04 20:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238916 F Kenneth Buechler 12544 High Bluff Drive, Suite 200
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-30 5,000 $11.96 53,519 No 4 M Direct
Common Stock Disposition 2018-08-30 5,000 $75.01 48,519 No 4 S Direct
Common Stock Disposition 2018-08-30 250 $0.00 48,269 No 4 G Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 G Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Disposition 2018-08-30 5,000 $0.00 5,000 $11.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,002 2010-05-12 2019-05-12 No 4 M Direct
Footnotes
  1. The weighted average sale price for these transactions was $75.0078 per share, with a range of $75.00 to $75.03. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
  2. Charitable donation.